• Je něco špatně v tomto záznamu ?

Application of Machine Learning to Assess Interindividual Variability in Rapid-Acting Insulin Responses After Subcutaneous Injection in People With Type 1 Diabetes

EM. Coales, RA. Ajjan, SM. Pearson, LL. O'Mahoney, N. Kietsiriroje, J. Brož, M. Holmes, MD. Campbell

. 2022 ; 46 (3) : 225-232.e2. [pub] 20210906

Jazyk angličtina Země Kanada

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018916

OBJECTIVES: Circulating insulin concentrations mediate vascular-inflammatory and prothrombotic factors. However, it is unknown whether interindividual differences in circulating insulin levels are associated with different inflammatory and prothrombotic profiles in type 1 diabetes (T1D). We applied an unsupervised machine-learning approach to determine whether interindividual differences in rapid-acting insulin levels associate with parameters of vascular health in patients with T1D. METHODS: We re-analyzed baseline pretreatment meal-tolerance test data from 2 randomized controlled trials in which 32 patients consumed a mixed-macronutrient meal and self-administered a single dose of rapid-acting insulin individualized by carbohydrate counting. Postprandial serum insulin, tumour necrosis factor (TNF)-alpha, plasma fibrinogen, human tissue factor (HTF) activity and plasminogen activator inhibitor-1 (PAI-1) were measured. Two-step clustering categorized individuals based on shared clinical characteristics. For analyses, insulin pharmacokinetic summary statistics were normalized, allowing standardized intraindividual comparisons. RESULTS: Despite standardization of insulin dose, individuals exhibited marked interpersonal variability in peak insulin concentrations (48.63%), time to peak (64.95%) and insulin incremental area under the curve (60.34%). Two clusters were computed: cluster 1 (n=14), representing increased serum insulin concentrations; and cluster 2 (n=18), representing reduced serum insulin concentrations (cluster 1: 389.50±177.10 pmol/L/IU h-1; cluster 2: 164.29±41.91 pmol/L/IU h-1; p<0.001). Cluster 2 was characterized by increased levels of fibrinogen, PAI-1, TNF-alpha and HTF activity; higher glycated hemoglobin; increased body mass index; lower estimated glucose disposal rate (increased insulin resistance); older age; and longer diabetes duration (p<0.05 for all analyses). CONCLUSIONS: Reduced serum insulin concentrations are associated with insulin resistance and a prothrombotic milieu in individuals with T1D, and therefore may be a marker of adverse vascular outcome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018916
003      
CZ-PrNML
005      
20220804135202.0
007      
ta
008      
220720s2022 xxc f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jcjd.2021.09.002 $2 doi
035    __
$a (PubMed)35568422
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxc
100    1_
$a Coales, Eleanor M $u School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom
245    10
$a Application of Machine Learning to Assess Interindividual Variability in Rapid-Acting Insulin Responses After Subcutaneous Injection in People With Type 1 Diabetes / $c EM. Coales, RA. Ajjan, SM. Pearson, LL. O'Mahoney, N. Kietsiriroje, J. Brož, M. Holmes, MD. Campbell
520    9_
$a OBJECTIVES: Circulating insulin concentrations mediate vascular-inflammatory and prothrombotic factors. However, it is unknown whether interindividual differences in circulating insulin levels are associated with different inflammatory and prothrombotic profiles in type 1 diabetes (T1D). We applied an unsupervised machine-learning approach to determine whether interindividual differences in rapid-acting insulin levels associate with parameters of vascular health in patients with T1D. METHODS: We re-analyzed baseline pretreatment meal-tolerance test data from 2 randomized controlled trials in which 32 patients consumed a mixed-macronutrient meal and self-administered a single dose of rapid-acting insulin individualized by carbohydrate counting. Postprandial serum insulin, tumour necrosis factor (TNF)-alpha, plasma fibrinogen, human tissue factor (HTF) activity and plasminogen activator inhibitor-1 (PAI-1) were measured. Two-step clustering categorized individuals based on shared clinical characteristics. For analyses, insulin pharmacokinetic summary statistics were normalized, allowing standardized intraindividual comparisons. RESULTS: Despite standardization of insulin dose, individuals exhibited marked interpersonal variability in peak insulin concentrations (48.63%), time to peak (64.95%) and insulin incremental area under the curve (60.34%). Two clusters were computed: cluster 1 (n=14), representing increased serum insulin concentrations; and cluster 2 (n=18), representing reduced serum insulin concentrations (cluster 1: 389.50±177.10 pmol/L/IU h-1; cluster 2: 164.29±41.91 pmol/L/IU h-1; p<0.001). Cluster 2 was characterized by increased levels of fibrinogen, PAI-1, TNF-alpha and HTF activity; higher glycated hemoglobin; increased body mass index; lower estimated glucose disposal rate (increased insulin resistance); older age; and longer diabetes duration (p<0.05 for all analyses). CONCLUSIONS: Reduced serum insulin concentrations are associated with insulin resistance and a prothrombotic milieu in individuals with T1D, and therefore may be a marker of adverse vascular outcome.
650    _2
$a krevní glukóza $x analýza $7 D001786
650    12
$a diabetes mellitus 1. typu $x komplikace $7 D003922
650    _2
$a fibrinogen $x terapeutické užití $7 D005340
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x farmakologie $x terapeutické užití $7 D007004
650    _2
$a injekce subkutánní $7 D007279
650    _2
$a inzulin $x terapeutické užití $7 D007328
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a krátkodobě působící inzuliny $x terapeutické užití $7 D061266
650    _2
$a strojové učení $7 D000069550
650    _2
$a inhibitor aktivátoru plazminogenu 1 $x terapeutické užití $7 D017395
650    _2
$a postprandiální období $7 D019518
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ajjan, Ramzi A $u Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
700    1_
$a Pearson, Sam M $u Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
700    1_
$a O'Mahoney, Lauren L $u Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, United Kingdom
700    1_
$a Kietsiriroje, Noppadol $u Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom
700    1_
$a Brož, Jan $u Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Holmes, Mel $u School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom
700    1_
$a Campbell, Matthew D $u Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; School of Nursing and Health Sciences, University of Sunderland, Sunderland, United Kingdom. Electronic address: matthew.campbell@sunderland.ac.uk
773    0_
$w MED00165234 $t Canadian journal of diabetes $x 2352-3840 $g Roč. 46, č. 3 (2022), s. 225-232.e2
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35568422 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135155 $b ABA008
999    __
$a ok $b bmc $g 1822487 $s 1170159
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 46 $c 3 $d 225-232.e2 $e 20210906 $i 2352-3840 $m Canadian journal of diabetes $n Can. j. diabetes $x MED00165234
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

    Možnosti archivace